Plyometric Strength-Endurance Exercise in Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Vigo
About this trial
This study aims to compare an adapted plyometric strength-endurance exercise program with conventional strength training in women who are breast cancer survivors or currently undergoing treatment and who participate in provincial support associations. The goal is to determine whether a targeted plyometric intervention can provide additional benefits in physical and mental health outcomes.
Using a cluster-randomized clinical trial design, the study will assess indicators such as functional capacity, muscle strength, fatigue levels, symptoms related to lymphedema, and overall quality of life. The findings are expected to contribute to a better understanding of how structured exercise programs can support recovery, physical function, and well-being in women affected by breast cancer.
Eligibility criteria
Qualifiers
Women aged 18 years or older.
Prior diagnosis of breast cancer.
History of mastectomy, including unilateral procedures, total breast surgery, or breast-conserving surgery.
Completion of postoperative chemotherapy or radiotherapy, when indicated.
Disqualifiers
Active metastasis to other organs or tissues (e.g., liver, kidney, lung, brain) or stage IV cancer that prevents safe participation in the therapeutic exercise program.
Current diagnosis of cardiovascular, respiratory, neuromuscular, or musculoskeletal diseases that contraindicate physical exercise or impair safe completion of the program.
Major surgery within the previous 6 months without medical clearance to resume physical activity.
Cognitive impairment or mental health conditions that limit comprehension of instructions or safe engagement in the intervention.
Trial design
Treatments tested in this trial
- Plyometric Strength-Endurance Training
- Conventional Strength Training
Treatment groups
51 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov